Company Announcements

Publication of Admission Particulars

Source: RNS
RNS Number : 5467T
Bunzl PLC
21 July 2020
 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

 

 

21 July 2020

 

BUNZL FINANCE PLC

 

ESTABLISHMENT OF A EURO MEDIUM TERM NOTE PROGRAMME AND PUBLICATION OF ADMISSION PARTICULARS

 

 

Bunzl Finance plc, a wholly-owned finance subsidiary of Bunzl plc, today announces that it has established a £1,000,000,000 Euro Medium Term Note Programme (the "Programme"). Pursuant to the Programme, Bunzl Finance plc, as Issuer, may from time to time issue notes up to a maximum outstanding aggregate nominal amount of £1,000,000,000 and Bunzl plc, as Guarantor, will unconditionally and irrevocably guarantee all payments of principal, interest and any other amounts payable on any notes issued under the Programme.

 

The Programme has been established to add to the range of financing facilities that Bunzl plc has in place to meet its funding requirements and provide additional flexibility as to how those requirements are met in the future.

 

In the context of the Programme, the following admission particulars (the "Admission Particulars") have been submitted and approved by the London Stock Exchange's International Securities Market today and are available for viewing:

 

Admission Particulars dated 21 July 2020 relating to the establishment of a £1,000,000,000 Euro Medium Term Note Programme, issued by Bunzl Finance plc, as Issuer, and unconditionally and irrevocably guaranteed by Bunzl plc, as Guarantor.

 

A copy of the Admission Particulars can be viewed on Bunzl plc's website at https://www.bunzl.com/investors/debt-investors.aspx.

 

This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

 

For further information, please contact:

 

Bunzl Finance plc

York House,

45 Seymour Street

London

W1H 7JT

United Kingdom

 

Email: paul.hussey@bunzl.com

Attention: Paul Hussey

 

DISCLAIMER - INTENDED ADDRESSES

Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Admission Particulars do not constitute an offer of securities for sale in the United States. The notes described herein and in the Admission Particulars have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the notes and on distribution of the Admission Particulars, see the "Subscription and Sale" section in the Admission Particulars.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

END

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDBLFLBDLFBBE